DXUPCLOSE
DxUpClose, Inc. is young company developing a point-of-care bacterial diagnostic that will perform an antibiotic sensitivity test in sixty minutes. The product is designed to screen for specific bacteria, regardless if the sample has the targeted bacteria, it will count the bacteria that are there and perform antibiotic sensitivity tests - all within sixty minutes. At the end of the test, the product will securely send a list of effective antibiotics to the Healthcare worker’s email or sm... artphone, so results can be rapidly interpreted by a physician who can then either write a prescription or ePrescribe the appropriate antibiotic. This will reduce the delay in optimal patient care present today by one to three days. Their device is designed to weigh less than sixteen ounces, fit in a pocket, run on batteries and survive temperature extremes, making it easy to transport while still retaining its diagnostic reliability.
DXUPCLOSE
Social Links:
Industry:
Biotechnology Health Diagnostics Medical Device
Founded:
2009-01-01
Address:
Frisco, Texas, United States
Country:
United States
Website Url:
http://www.dxupclose.com
Total Employee:
1+
Status:
Active
Contact:
5754487404
Total Funding:
1000 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag
Current Advisors List
Current Employees Featured
Founder
Investors List
Golden Seeds
Golden Seeds investment in Series A - DxUpClose
Green Park & Golf Ventures
Green Park & Golf Ventures investment in Seed Round - DxUpClose
Official Site Inspections
http://www.dxupclose.com
- Host name: 104.21.21.119
- IP address: 104.21.21.119
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "DxUpClose"
DxUpClose Company Profile | Management and Employees List
DxUpClose Profile and History. DxUpClose, Inc. is an early stage in vitro diagnostic company developing a novel medical device to help physicians better care for their patients suffering …See details»
DxUpClose Company Profile 2024: Valuation, Funding & Investors
DxUpClose General Information Description. Developer of a point-of-care bacterial diagnostic device intended to perform antibiotic sensitivity tests. The company's device includes the …See details»
DxUpClose, Inc. - LinkedIn
DxUpClose, Inc. is an early stage in vitro diagnostic company developing a novel medical device to help physicians better care for their patients suffering from an infectious disease.See details»
DxUpClose - Funding, Financials, Valuation & Investors - Crunchbase
DxUpClose develops a point-of-care bacterial diagnostic that performs an antibiotic sensitivity test in 60 minutes. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
DxUpClose, Inc. | Frisco, TX, USA Startup - gust.com
Cyndi Nickel founded DxUpClose, Inc. in 2009 and leads all of the company’s operations and development. Her background includes twenty-four years of experience at Hewlett-Packard in …See details»
DxUpClose - Contacts, Employees, Board Members, Advisors
DxUpClose develops a point-of-care bacterial diagnostic that performs an antibiotic sensitivity test in 60 minutes.See details»
DxUpClose | VentureRadar
DxUpClose, Inc. is an early stage in vitro diagnostic company developing a novel medical device to help physicians provide better care for their patients suffering from an infectious disease. …See details»
DxUpClose - Overview, News & Competitors | ZoomInfo.com
DxUpClose, Inc. is an early stage in vitro diagnostic company developing a novel medical device to help physicians better care for their patients suffering from an infectious disease. Read …See details»
DxUpClose - Company Profile - Tracxn
Nov 5, 2024 DxUpClose is developing a point-of-care bacterial diagnostic that will perform an antibiotic sensitivity test in sixty minutes. The product is designed to screen for specific …See details»
DxUpClose Inc - Company Profile and News - Bloomberg Markets
Company profile page for DxUpClose Inc including stock price, company news, executives, board members, and contact informationSee details»
DxUpClose - Tech Stack, Apps, Patents & Trademarks - Crunchbase
DxUpClose develops a point-of-care bacterial diagnostic that performs an antibiotic sensitivity test in 60 minutes.See details»
How Hubert Zajicek Jump-Starts Companies - D Magazine
It was 2011, and entrepreneur Cyndi Nickel was in search of a business incubator. Her Austin-based biotech firm DxUpClose, founded in 2009, was using lab space at Texas State …See details»
DxUpClose - VentureRadar
Similar Companies: Vitamica United Kingdom Privately Held Vitamica was established in early 2018 as a spin-out company from the University of Bristol. Taking optical technology from the …See details»
Golden Seeds Invests In DxUpClose, Disruptive Technology That …
Summary "DxUpClose will bring a state of the art diagnostic solution to sufferers of a very painful illness, reduce healthcare costs and assist doctors in providing the best healthcare to their …See details»
DxUpClose - Crunchbase
DxUpClose develops a point-of-care bacterial diagnostic that performs an antibiotic sensitivity test in 60 minutes.See details»
Meta Developers
Sep 9, 2024 Before you can distribute an app on the platform, you need to create or join an organization on the Developer Dashboard.An organization represents the company or …See details»
James Biard - Founder, Inventor, and Scientific Advisor
Dr. James Biard is a co-founder of DxUpClose and one of the inventors responsible for creating the company’s diagnostic sensor. Currently on the staff of Texas A&M University as an …See details»
Cyndi Nickel - Crunchbase Person Profile
Cyndi Nickel founded DxUpClose, Inc. in 2009 and leads all of the company’s operations and development. Her background includes twenty-four years of experience at Hewlett-Packard in …See details»